Regulation

Massachusetts Cannabis Commission Announces Fall Regulatory Overhaul

mm
Add MyCannabis.com to your preferred sources on Google

The Massachusetts Cannabis Control Commission on September 16, 2026, announced the start of a broad regulatory overhaul, with a series of public meetings beginning September 17, 2026, and topics including cannabis testing protocols, medical marijuana licensing, registered agent training, and advertising rules on the agenda. The agency described the effort as one of the largest to modernize cannabis regulations in its history.

The new regulatory round is the Commission’s third of 2026, following the March extension of delivery license exclusivity and emergency regulations promulgated in September 2026 that increased retail ownership caps as required by Chapter 65 of the Acts of 2026.

Chair Chris Harding said the Commission has already been at work in 2026 remodeling its regulations as the industry continues to evolve and looks forward to taking on a wide range of updates in the fall. “Modernizing our regulations will keep us in line with requirements under Ch. 65 but will also allow us to better protect public health and safety, improve the business climate, and increase consumer confidence,” Harding said.

In a change from previous updates, internal regulatory working groups overseen by individual Commissioners will provide proposed regulatory language for approval or amendment at upcoming public meetings. The Commission said the change is aimed at speeding up the regulatory process while Commissioners maintain final authority over policy approvals and adhere to the Open Meeting Law.

The regulatory updates were introduced at the Commission’s August 13, 2026, meeting and continue on September 17 with a review of changes to medical marijuana licensing and the medical program as a whole.

Medical Marijuana and Testing Changes

Chapter 65 of the Acts of 2026 ended the vertical integration requirement for medical marijuana establishments. Commissioners will review a new standalone medical dispensary license type and modifications that would authorize transfers from adult-use licensees to medical marijuana establishments. Commissioners will also discuss other changes to the medical program, including eliminating a residency requirement for patients and improving access for pediatric patients with life-threatening illnesses.

The Commission is also establishing a new section of 935 CMR dedicated to cannabis testing requirements, bringing its testing standards together in one comprehensive regulatory framework. In developing the section, the Commission said it will consider updates proposed by Commission staff, the Regulatory Testing Working Group, roundtables with Independent Testing Laboratories, and feedback received through recent public testimony and comment. The new section is intended to provide clear, consistent, and more transparent requirements for the testing of cannabis and cannabis products in Massachusetts and will be the focus of a public meeting in early October 2026.

Executive Director Travis Ahern said the issues in this round include “some of the most pressing issues facing the state’s evolving cannabis industry, including a major cannabis testing update that will complement recent Commission efforts to bolster product safety.” He said the Commission looks forward to making the changes as efficiently as possible while continuing ongoing work to launch social consumption licenses and implement updates under Chapter 65.

Meetings scheduled through the end of 2026 will also take up topics outside the Chapter 65 requirements, including recommendations that emerged from a Red Tape Removal committee convened earlier in 2026. The listed topics include how municipalities may opt out of allowing cannabis delivery and transporting cannabis over state waterways for Dukes County and Nantucket County.

The agenda also includes reviewing the annual Responsible Vendor Training requirement, allowing for consideration of statewide license caps, advertising, marketing and loyalty program rules, authorizing the sale of cannabis seeds at adult- and medical-use retail stores, combining transporter licenses, considering agent-centric badging, and reviewing notices of deficiency requirements.

Commissioners plan to vote on three sets of draft regulations at a public meeting in December 2026. Following that vote, the Commission would open the proposed regulations for public comment, hold a public hearing in early 2027, and take a final vote in March 2027.

Earlier 2026 Regulatory Rounds

In the first of the year’s rounds, delivery licenses remained exclusively available to participants in the Commission’s equity programs until April 2029 under regulatory changes promulgated by the Secretary of the Commonwealth on March 27, 2026. The Commission unanimously approved the regulations at its March 6, 2026, public meeting after weeks of deliberation that included consideration of an evaluation of the policy’s success by an agency working group in partnership with the UMass Donahue Institute, along with stakeholder feedback from a public comment period and public hearing.

During the exclusivity period, adult-use Marijuana Delivery Courier, Delivery Operator, and Microbusiness with Delivery Endorsement business models are set aside for those with majority ownership made up of Social Equity Program participants and Certified Economic Empowerment Priority Applicants. The state’s initial exclusivity period began April 1, 2022, and was extended by one year in 2025. Under the new regulations, the Commission may further extend the period by vote at its discretion and will collect data on the goals of the exclusivity policy and report that data to the public every six months.

The March package also updated the Commission’s Secret Shopper off-the-shelf testing program, one of the agency’s investigations and enforcement tools that allows individuals to conduct random, off-the-shelf testing of cannabis products. The changes allow third-party vendors or contractors, such as nonprofits, research institutions, and other legal entities, to enter into agreements with the Commission to act as secret shoppers, and clarify the processes for documentation, custody, preservation, and transportation for Secret Shopper activities.

The second round followed the signing of Chapter 65 of the Acts of 2026, An Act Modernizing the Commonwealth’s Cannabis Laws, on April 19, 2026. The law gave the Commission 60 days to increase the adult-use retail license cap from three to up to six licenses, and it raised the daily purchase limit from 1 to 2 ounces of cannabis immediately on April 19.

Under the statute, only Social Equity Businesses, businesses comprised of majority ownership of individuals who are Social Equity Program participants or Economic Empowerment Priority Applicants, are eligible to receive a sixth retail license during the first 12 months after the Commission begins accepting applications; during that period, the Commission may not grant more than five retail licenses to any licensee that is not a Social Equity Business. The Commission approved the emergency regulations on June 17, 2026, accepted written public comments from July 3 through July 30, 2026, and held a public hearing on July 30, 2026.

The emergency regulations also allow Social Equity Businesses to possess up to six retail licenses and a single licensee to hold up to three fully integrated Medical Marijuana Establishment licenses, and they increase the financial interest a person or entity can hold in a license without being counted toward the license cap from 10 percent to less than 20 percent, so long as that person or entity does not otherwise have direct or indirect control.

Ava Morales is an AI-generated analyst at MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.